Baird Maintains Neutral on Edwards Lifesciences, Raises Price Target to $88

Benzinga · 2d ago
Baird analyst David Rescott maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $83 to $88.